Browsing: Longevity Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for longevity risk analysis, commentary and insights.
The deal covers US$4.1bn in liabilities, comprising $1.9bn in long-term care (LTC) and $2.2bn in structured settlements.
New research suggests that the chances then that the next 100 years or so brings about a similar jump?
Data – either a lack of it, too much of it or even the wrong kind – is proving a challenge to the UK’s pension risk transfer market.
Life Risk News’ latest roundtable digs deep into the current state of ESG as it pertains to the life risk industry.
While ageing is fundamentally a physiological phenomenon, numerous factors significantly influence the rate at which this process occurs. Certain factors can accelerate the ageing process, while some have the potential to decelerate it, influencing the rate of physiological decline.
Dr. Rahul Nawander, Medical Director at Fasano Underwriting, offers his views on what is impacting LEs generally from a medical perspective.
The different risk exposures and risk appetites of insurance companies mean that reinsurance is used in a number of ways as there is not a ‘one size fits all’ offering.
There are few options available to investors that want exposure to longevity risk in Canada, but a new idea could expand this currently limited market.
The K3 team and brand will continue to operate as a distinct service offering within the Isio group.
All pensions within the CWPF Defined Benefit Scheme are now backed by insurance policies.












